Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial of Induction Versus Expectant Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Nulliparous - no previous pregnancy beyond 20 weeks~2. Singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age.~3. Gestational age at randomization between 38 weeks 0 days and 38 weeks 6 days inclusive based on clinical information and evaluation of the earliest ultrasound.~Exclusion Criteria:~1. Project gestational age at date of first ultrasound is \> 20 weeks 6 days~2. Plan for induction of labor prior to 40 weeks 5 days~3. Plan for cesarean delivery or contraindication to labor~4. Breech presentation~5. Signs of labor (regular painful contractions with cervical change)~6. Fetal demise or known major fetal anomaly~7. Heparin or low-molecular weight heparin during the current pregnancy~8. Placenta previa, accreta, vasa previa~9. Active vaginal bleeding greater than bloody show~10. Ruptured membranes~11. Cerclage in current pregnancy~12. Known oligohydramnios, defined as AFI \< 5 or MVP \< 2~13. Fetal growth restriction, defined as EFW \< 10th percentile~14. Known HIV positivity because of modified delivery plan~15. Major maternal medical illness associated with increased risk for adverse pregnancy outcome (for example, any diabetes mellitus, lupus, any hypertensive disorder, cardiac disease, renal insufficiency)~16. Refusal of blood products~17. Participation in another interventional study that influences management of labor at delivery or perinatal morbidity or mortality~18. Delivery planned elsewhere at a non-Network site

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Expectant Management (Type: NO_INTERVENTION): Expectant management (unless a medical indication arises) until at least 40 weeks 5 days.
- Elective Induction of Labor (Type: OTHER): Elective induction of labor between 39 weeks 0 days and 39 weeks 4 days

Based on this trial design, predict the completion outcome and termination type (if applicable).